Study on the Diagnosis and Management of CLL in Italy by GIMEMA
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Study ID
- NCT04867915
- Status
- Recruiting
Conditions
- Chronic Lymphocytic Leukemia
- MBL-CLL - Monoclonal B-Cell Lymphocytosis Chronic Lymphocytic Leukaemia-Type
- Small Lymphocytic Lymphoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
retrospective and prospective multicenter observational clinical and biological data collection from all patients with newly diagnosed CLL, SLL or MBL. retrospective cohort: all cases with a diagnosis between January 1st 2010 and August 31th 2021. prospective cohort: all patients with a diagnosis between September 1st 2021 and September 1st 2025.
Key Dates
- First listed
- Apr 30, 2021
- Start date
- Oct 13, 2021
- Status verified
- Mar 2025
- Primary completion
- Oct 31, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 12,500 participants (estimated)
Primary Outcome Measure
Describe the diagnosis and management of CLL patients [ Time Frame: at 1 year for the prospective cohort and at 4 years for the retrospective cohort ]
Central Contacts
- Paola Fazi0670390528
- Enrico Crea0670390514
Find similar trials
Related Studies
- Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)Recruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- A Long-term Extension Study of PCI-32765 (Ibrutinib)PHASE3 · Recruiting · Janssen Research & Development, LLC · Orange, California
- Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)PHASE1 · Recruiting · Baylor College of Medicine · Houston, Texas
- The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative RegimenRecruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina